Bariatric Surgery ‘Reprograms’ Kidneys in Teens with Type 2 Diabetes: A New Hope for Combating Diabetic Kidney Disease
A groundbreaking study published in The Journal of Clinical Investigation reveals that bariatric surgery doesn’t just aid weight loss in adolescents with type 2 diabetes and obesity – it fundamentally alters kidney biology, potentially offering a pathway to reverse or prevent diabetic kidney disease. Researchers at Northwestern University and collaborating institutions have identified specific molecular mechanisms at play, opening doors for non-surgical treatments in the future.
The Rising Tide of Type 2 Diabetes in Youth
The prevalence of type 2 diabetes in young people is a growing concern. According to a recent report from the Centers for Disease Control and Prevention, rates have been steadily increasing for the past two decades and are projected to continue rising over the next 40 years. This is particularly alarming because type 2 diabetes manifests more aggressively in children than in adults, leading to faster progression to insulin therapy and more rapid multi-organ damage.
Why Teens are More Vulnerable to Kidney Disease
Adolescents with type 2 diabetes and obesity are at a heightened risk of developing diabetic kidney disease. This occurs when chronically high glucose levels damage the kidneys’ filtration units, leading to protein loss and impaired kidney function. “Type 2 diabetes in kids is a much more aggressive disease than in the adult form,” explains Dr. Thomas Inge, the Lydia J. Fredrickson Board Designated Professor of Pediatric Surgery. “They progress to a need for insulin therapy five times faster than adults do and the multi-organ damage similarly comes faster.”
How Bariatric Surgery Impacts Kidney Function
Bariatric surgery, particularly sleeve gastrectomy (removal of a large portion of the stomach), has proven effective in treating type 2 diabetes in some adolescents. The new research delves into how this happens at a molecular level. Scientists analyzed kidney biopsy samples from five adolescents before and 12 months after surgery, alongside data from a larger study, the Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS).
The study revealed significant changes post-surgery: reduced kidney hyperfiltration, decreased total kidney volume, and lower levels of microalbuminuria – an early indicator of kidney damage. Crucially, the research identified a “reprogramming” of kidney cells, with changes in gene expression related to energy metabolism and inflammation.
Molecular Mechanisms at Play: AMPK, FOXO3, and mTORC1
Specifically, the study highlighted the upregulation of AMPK and FOXO3 proteins, which are key regulators of cellular energy homeostasis. Researchers also observed a decrease in metabolic signaling related to mTORC1 activity, a pathway involved in cell growth and proliferation. These changes promote autophagy (a cellular “self-cleaning” process) and energy conservation within the kidney cells.
“There’s a lot of reprogramming of the kidney cells that seems to be independent of the weight loss and that drives some of the downstream mechanisms that we see in kidney function, reduced inflammation and these energy conservation pathways,” said Dr. Justin Ryder, associate professor of Surgery in the Division of Pediatric General Surgery and of Pediatrics.
Beyond Surgery: The Potential for New Treatments
The findings suggest that mimicking these molecular changes could lead to non-surgical treatments for diabetic kidney disease. “Some of these specific targets that we identified could potentially be targets for future medications or combinations of medications to treat diabetic kidney disease, potentially without the need for surgery,” Dr. Ryder stated. Yet, he emphasized that surgery remains a vital treatment option until such therapies are developed.
Dr. Inge added that the energy conservation observed after surgery may be more durable than traditional calorie restriction, as it doesn’t trigger the same intense hunger and compensatory eating behaviors.
What Does This Mean for the Future?
This research represents a significant step forward in understanding the complex relationship between obesity, type 2 diabetes, and kidney disease. It opens up exciting possibilities for developing targeted therapies that can protect the kidneys of young people at risk. Further research is needed to determine if less invasive bariatric procedures offer similar long-term benefits and to identify the optimal combination of medications to achieve these positive outcomes.
Did you know?
Adolescents with type 2 diabetes progress to needing insulin therapy five times faster than adults, highlighting the aggressive nature of the disease in youth.
Pro Tip:
Early intervention is key. If you are concerned about your child’s weight or risk factors for type 2 diabetes, consult with a healthcare professional.
FAQ
Q: Is bariatric surgery the only option for treating diabetic kidney disease in adolescents?
A: Currently, it’s one of the most effective options, but research is ongoing to develop non-surgical treatments.
Q: What is mTORC1 and why is its downregulation beneficial?
A: mTORC1 is a pathway that promotes cell growth. Reducing its activity can assist conserve energy and reduce inflammation in kidney cells.
Q: What is the Teen-LABS study?
A: The Teen-Longitudinal Assessment of Bariatric Surgery is a long-term study investigating the effects of bariatric surgery on adolescents with severe obesity.
Q: What are the next steps in this research?
A: Researchers are planning further studies to identify specific drug targets and develop non-surgical therapies to mimic the benefits of bariatric surgery.
Want to learn more about adolescent health and diabetes? Explore related articles on our website or subscribe to our newsletter for the latest updates.
